sponsored
PatientsVille.com Logo

PatientsVille

Gastritis Medical Research Studies

Up-to-date List of Gastritis Medical Research Studies

What Research is Being Done?

A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies. Following list includes both interventional and observational studies.

Latest Gastritis Medical Research Studies

Rank Status Study
1 Unknown  Esomeprazole Treatment for Patients With Lymphocytic Gastritis
Condition: Lymphocytic Gastritis
Intervention: Drug: Esomeprazole
Outcome Measures: The primary objective is to assess the healing rate of;   patients with lymphocytic Gastritis irrespective of H. pylori status after treatment;   with esomeprazole 20 mg twice daily for 2 weeks.;   Secondary objective of the study are to evaluate the grade and activity of Gastritis before and after;   treatment according to updated Sydney classification, to assess the clinical GI symptoms at baseline and after 3 months;   and to evaluate influence of the H. pylori-Status
2 Unknown  Study of the Chinese Prescription Weiqi Decoction on Chronic Atrophic Gastritis
Condition: Gastritis
Intervention: Drug: Weiqi decotion
Outcome Measures: Symptoms and conditions of tongue and pulse,the gastroscopy and pathological change;   Indicates of liver and renal function
3 Recruiting A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034
Conditions: Acute Gastritis;   Chronic Gastritis
Interventions: Drug: DA-6034;   Drug: Rebamipide 300mg
Outcome Measures: The number of erosions comparing the before and after the administration. For example, if the number of the erosion is 0, the score is 1 (normal).;   The number of erosions diagnosed by the gastroscope;   The severity of the digestive symptoms (Scale of 1 to 5)
4 Not yet recruiting Gastropanel for Gastric Atrophy and Cancer Risk Assessment
Conditions: Gastritis, Atrophic;   Stomach Neoplasms
Interventions: Procedure: GastroPanel test;   Procedure: Gastroscopy
Outcome Measure: Sensitivity and Specificity of the GastroPanel test for the detection of AG
5 Unknown  The Revolutions of Helicobacter Pylori Infection, Bacterial Density, and Histological Features After Antrectomy
Conditions: Helicobacter Pylori Infection;   Peptic Ulcer;   Bile Reflux;   Gastritis
Intervention:
Outcome Measure:
6 Unknown  The Metabolic Contribution of the Human Microbiota to Resting Energy Expenditure
Condition: Gastritis
Intervention: Procedure: Resting Energy Expenditure examination
Outcome Measure:
7 Recruiting Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality
Conditions: Helicobacter Pylori Infections;   Atrophic Gastritis;   Gastric Cancer
Intervention: Drug: Triple therapy
Outcome Measures: Gastric cancer mortality;   Gastric cancer incidence;   All-cause mortality;   Incidence of- and mortality from other medical conditions
8 Unknown  Activation and Recruitment of GIL During Hp Infection
Conditions: Helicobacter Gastritis;   Dyspepsia
Intervention:
Outcome Measure:
9 Recruiting Role of Statin on the Gastric Inflammation in Patients at High Risk of Gastric Cancer
Condition: Early Gastric Cancer or Gastric Adenoma
Interventions: Drug: Arm1: Statin;   Drug: Arm2: Placebo
Outcome Measure: Proportion of the patients with high-risk (III/IV) OLGA stages
10 Not yet recruiting Endofaster Test for Helicobacter Pylori Detection in Patients on Proton Pump Inhibitor Therapy
Condition: Helicobacter Infections
Interventions: Procedure: Gastroscopy;   Device: EndoFaster test;   Other: Clo test;   Other: Faecal Helicobacter pylori antigen
Outcome Measure: Diagnostic accuracy of the EndoFaster test in H. pylori diagnosis
11 Recruiting A Study Comparing Billroth II With Roux-en-Y Reconstruction for Gastric Cancer
Conditions: Gastric Cancer;   Stomach Cancer;   Gastrectomy
Intervention: Procedure: Roux-en-Y or Billroth II
Outcome Measures: The aim of this study is to compare Billroth II and Roux En Y reconstruction after radical distal subtotal gastrectomy for gastric cancer in terms of postoperative outcomes.;   Quality of life pre and post operatively will be compared between Billroth II and Roux En Y reconstruction after radical distal subtotal gastrectomy.;   Gastrointestinal symptoms assessment;   Assessing nutritional status;   Grading of Gastritis and/or esophagitis on endoscopy
12 Unknown  Esomeprazole, Moxifloxacin and Amoxicilin for Rescue Therapy of Helicobacter Pylori Infection
Conditions: Helicobacter Pylori Infection;   Chronic Gastritis
Interventions: Drug: esomeprazole;   Drug: moxifloxacin;   Drug: amoxicillin
Outcome Measures: Efficacy of a combination of esomeprazole (E), moxifloxacin (M) and amoxicillin (A) for third line therapy of H. pylori infection.;   Comparison of EMA 7 days versus EMA 14 days. Hypothesis: superiority of EMA 14 days 4 weeks after end of eradication therapy;   Tolerability,safety, post treatment resistance, influence of host genetics (CYP status) and pathogenicity factors of H. pylori on treatment success.
13 Unknown  Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection
Conditions: Helicobacter Infections;   Gastritis;   Gastric Ulcer;   Duodenal Ulcer
Intervention: Drug: rabeprazole, amoxicillin, clarithromycin, metronidazole
Outcome Measures: Which treatment yields the higher re-eradication rate of H. pylori infection;   Side effects
14 Unknown  Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori
Conditions: Helicobacter Infections;   Gastritis;   Gastric Ulcer;   Duodenal Ulcer
Intervention: Drug: Lansoprazole, clarithromycin, amoxicillin
Outcome Measures: Whether the tailored treatment yields a higher eradication rate in comparison with the standard treatment;   Cost-effectiveness of the tailored strategy
15 Recruiting Control of Helicobacter Pylori Infection by Probiotics
Condition: Helicobacter Pylori Infection
Interventions: Dietary Supplement: L. reuteri DSM 17938 and ATCC PTA 6475;   Other: Placebo
Outcome Measures: to decrease H. pylori gastric load;   To decrease dyspeptic symptoms
16 Recruiting High Dose PPI Triple Therapy Versus Sequential Therapy for Helicobacter Pylori Eradication
Conditions: Dyspepsia;   Helicobacter-associated Gastritis;   Stomach Disorders
Interventions: Drug: Double dose of PPI;   Drug: sequence of drug use
Outcome Measures: Eradication rate;   Adherence rate/adverse events;   Prevalence of clarithromycin resistance HP;   Symptomatic responses regarding dyspeptic symptoms after HP eradication
17 Recruiting Concomitant Therapy of H. Pylori
Condition: Gastritis, Gastric Ulcer, and Duodenal Ulcer
Intervention: Drug: amoxicillin, clarithromycin, metronidazole, rabeprazole
Outcome Measure: Evaluation of the efficacy of concomitant therapy for eradication of Helicobacter pylori
18 Recruiting HLA-DRB1 and HLA-DQB1 Genotyping for Autoantibody-positive and -Negative Patients With Atrophic Glossitis or Burning Mouth Syndrome
Condition: Atrophic Glossitis, Burning Mouth Syndrome
Intervention: Dietary Supplement: Supplementation of vitamin B complex, C, B12, folic acid, Iron and Zinic
Outcome Measures: Number of participants with finding the HLA-DRB1 and HLA-DQB1;   Number of participants with finding the HLA-DRB1-DQB1 haplotype
19 Recruiting Systematic Screening for Risk-factors for Ulcer Bleeding Before Anti-thrombotic Treatment
Conditions: Coronary Occlusion/Thrombosis;   Peptic Ulcer Hemorrhage
Intervention: Other: Screening for risk factors for ulcer bleeding
Outcome Measures: Admission for ulcer bleeding or haemorrhagic Gastritis;   Compliance with antithrombotic medicine;   Identification of patients with Benefit of Proton pump inhibitor Prophylaxis;   Gastrointestinal bleeding;   Uncomplicated ulcers;   Death;   Acute coronary syndrome
20 Not yet recruiting Rebamipide in Combination With Esomeprazole in the Management of Asian Patients With Functional Dyspepsia
Condition: Dyspepsia
Interventions: Drug: Rebamipide;   Drug: Placebo (for Esomeprazole);   Drug: Esomeprazole
Outcome Measures: Dyspepsia symptoms;   quality of life

These studies may lead to new treatments and are adding insight into Gastritis etiology and treatment.

A major focus of Gastritis research is the development of new drugs and other treatment options. Studies seek to identify new drugs to treat various related disorders and to find safer, more effective doses for medications already being used. Other research is aimed at identifying receptors or drug targets.


Discuss Gastritis